Detection of p53 gene mutations in cytopathology and biopsy specimens from patients with lung cancer

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 4 I, 1996, Pages 1117-1123

  Murakami, Isao ^a   Fujiwara, Yasuhiro ^a   Yamaoka, Naoki ^a   Hiyama, Keiko ^a   Ishioka, Shinichi ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IRINOTECAN; MITOMYCIN; PACLITAXEL; PROTEIN P53; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER SURVIVAL; CYTOPATHOLOGY; FEMALE; FIBEROPTIC BRONCHOSCOPY; GENE MUTATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEEDLE BIOPSY; PRIORITY JOURNAL; THORACOCENTESIS;

EID: 0029859649     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.4.8887616     Document Type: Article

References (30)

1. Harris, C. C., and M. Hollstein. 1993. Clinical implication of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318-1327.
2. Takahashi, T., T. Takahashi, H. Suzuki, T. Hida, Y. Sekido, Y. Ariyoshi, and R. Ueda. 1991. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6:1775-1778.
3. D'Amico, D., D. Carbone, T. Mitsudomi, M. Nau, J. Fedorko, E. Russel, B. Johnson, D. Buchhagen, S. Bodner, R. Phelps, A. Gazdar, and J. D. Minna. 1992. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene 7:339-346.
4. Sameshima, Y., Y. Matsuno, S. Hirohashi, Y. Shimosato, H. Mizoguchi, T. Sugimura, M. Terada, and J. Yokota. 1992. Alterations of the p53 gene are common and critical events for maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 7:451-457.
5. Lohmann, D., B. Putz, U. Reich, J. Bohn, H. Prauer, and H. Hofler. 1993. Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data. Am. J. Pathol. 142:907-915.
6. Kishimoto, Y., Y. Murakami, M. Shiraishi, K. Hayashi, and T. Sekiya. 1992. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinoma of the lung. Cancer Res. 52:4799-4804.
7. Suzuki, H., T. Takahashi, T. Kuroishi, M. Suyama, Y. Ariyoshi, T. Takahashi, and R. Ueda. 1992. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 52:734-736.
8. Horio, Y., T. Takahashi, T. Kuroishi, K. Hibi, M. Suyama, T. Niimi, K. Shimokata, K. Yamakawa, Y. Nakamura, R. Ueda, and T. Takahashi. 1993. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res. 53:1-4.
9. Mitsudomi, T., T. Oyama, T. Kusano, T. Osaki, R. Nakanishi, and T. Sirakusa. 1993. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J. Natl. Cancer Inst. 85:2018-2023.
10. Isobe, T., K. Hiyama, Y. Yoshida, Y. Fujiwara, and M. Yamakido. 1994. Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I diseases after curative resection. Jpn. J. Cancer Res. 85:1240-1246.
11. Ryberg, D., E. Kure, S. Lystad, V. Skaug, L. Stangeland, I. Mercy, A.-L. Borresen, and A. Haugen. 1994. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res. 54:1551-1555.
12. Shirasawa, S., K. Urabe, Y. Yanagawa, K. Toshitani, T. Iwama, and T. Sasazuki. 1991. p53 gene mutations in colorectal tumors from patients with familial polyposis coli. Cancer Res. 51:2874-2878.
13. Hermanek, P., and L. H. Sobin. 1987. TNM Classification of Malignant Tumors, 4th ed. International Union Against Cancer (UICC). Springer-Verlag, Berlin. 69-73.
14. - murine thymocytes. Proc. Natl. Acad. Sci. U.S.A. 85:6082-6086.
15. Hsu, I. C., R. A. Metcalf, T. Sun, J. A. Welsh, N. J. Wang, and C. C. Harris. 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428.
16. Chumakov, P. M., V. P. Almazov, and J. R. Jenkins. 1991. New nucleotide sequence data on the EMBL file server. Nucleic Acids Res. 19:4804.
17. Hiyama, K., S. Ishioka, Y. Shirotani, K. Inai, E. Hiyama, I. Murakami, T. Isobe, T. Inamizu, and M. Yamakido. 1995. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10:937-944.
18. Kaplan, E., and P. Meier. 1958. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481.
19. Peto, R., and J. Peto. 1972. Asymptotically efficient rank invariant test procedures (with discussion). J. R. Stat. Soc. A. 135:185-206.
20. Cox, D. R. 1972. Regression models and life tables (with discussion). J. R. Stat. Soc. B. 34:187-220.
21. Boss, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 9:4682-4689.
22. Sundaresan, V., P. Ganly, P. Hasleton, R. Rudd, G. Sinha, N. M. Bleehen, and P. Rabbitts. 1992. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989-1997.
23. Hirano, T., B. Franzen, H. Kato, Y. Ebihara, and G. Auer. 1994. Genesis of squamous cell lung carcinoma: sequential changes of proliferation, DNA ploidy, and p53 expression. Am. J. Pathol. 144:296-302.
24. Walker, C., L. J. Robertson, M. W. Myskow, N. Pendleton, and G. R. Dixon. 1994. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer 70:297-303.
25. Dowell, S. P., P. O. G. Wilson, N. W. Derias, D. P. Lane, and P. A. Hall. 1994. Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res. 54:2914-2918.
26. Mitsudomi, T., S. Lam, T. Shirakusa, and A. F. Gazdar. 1993. Detection and sequencing of the p53 gene mutations in bronchial biopsy samples in patients with lung cancer. Chest 104:362-365.
27. Mao, L., R. H. Hruban, J. O. Boyle, M. Tockman, and D. Sidransky. 1994. Detection of oncogene mutations in sputum precedes diagnosis of lime cancer. Cancer Res. 54:1634-1637.
28. Moyret, C., C. Theillet, P. L. Puig, J.-P. Moles, G. Thomas, and R. Hamelin. 1994. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 9: 1739-1743.
29. Lee, J. M., and A. Bernstein. 1993. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 90:5742-5746.
30. Fujiwara, T., E. A. Grimm, T. Mukhopadhyay, W. W. Zhang, L. B. Owen-Schaub, and J. A. Roth. 1994. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54:2287-2291.